Literature DB >> 27443925

Clonal analysis of gene loss of function and tissue-specific gene deletion in zebrafish via CRISPR/Cas9 technology.

F De Santis1, V Di Donato1, F Del Bene1.   

Abstract

In the last few years the development of CRISPR/Cas 9-mediated genome editing techniques has allowed the efficient generation of loss-of-function alleles in several model organisms including zebrafish. However, these methods are mainly devoted to target-specific genomic loci leading to the creation of constitutive knock-out models. On the contrary, the analysis of gene function via tissue- or cell-specific mutagenesis remains challenging in zebrafish. To circumvent this limitation, we present here a simple and versatile protocol to achieve tissue-specific gene disruption based on the Cas9 expression under the control of the Gal4/upstream activating sequence binary system. In our method, we couple Cas9 with green fluorescent protein or Cre reporter gene expression. This strategy allows us to induce somatic mutations in genetically labeled cell clones or single cells, and to follow them in vivo via reporter gene expression. Importantly, because none of the tools that we present here are restricted to zebrafish, similar approaches are readily applicable in virtually any organism where transgenesis and DNA injection are feasible.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Clonal analysis; Cre recombinase; Genome editing; Tissue-specific knockout; Zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27443925     DOI: 10.1016/bs.mcb.2016.03.006

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  1 in total

1.  Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing.

Authors:  Hang Yin; Xiaoling Yuan; Lihua Luo; Yichao Lu; Bing Qin; Junlei Zhang; Yingying Shi; Chunqi Zhu; Jie Yang; Xiang Li; Mengshi Jiang; Zhenyu Luo; Xinyu Shan; Dawei Chen; Jian You
Journal:  Adv Sci (Weinh)       Date:  2020-06-13       Impact factor: 16.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.